Guardian Pharmacy Services (NYSE:GRDN) Shares Down 5% – Should You Sell?

Guardian Pharmacy Services, Inc. (NYSE:GRDN)’s share price fell 5% on Thursday . The stock traded as low as $19.23 and last traded at $19.24. 140,536 shares were traded during mid-day trading, a decline of 26% from the average session volume of 189,088 shares. The stock had previously closed at $20.26.

Analysts Set New Price Targets

Several research analysts have recently commented on GRDN shares. Raymond James started coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They issued an “outperform” rating and a $21.00 price objective on the stock. Stephens initiated coverage on Guardian Pharmacy Services in a research note on Tuesday, October 22nd. They issued an “overweight” rating and a $21.00 price target on the stock. Finally, Truist Financial increased their price objective on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, November 15th.

Guardian Pharmacy Services Stock Down 2.3 %

The stock’s fifty day moving average price is $21.82.

Guardian Pharmacy Services (NYSE:GRDN) last announced its earnings results on Tuesday, November 12th. The company reported ($2.00) EPS for the quarter, missing analysts’ consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to the consensus estimate of $303.21 million. On average, analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

Insider Transactions at Guardian Pharmacy Services

In other news, Director Steven D. Cosler bought 7,000 shares of the firm’s stock in a transaction dated Tuesday, November 19th. The stock was purchased at an average price of $21.22 per share, with a total value of $148,540.00. Following the transaction, the director now owns 17,713 shares of the company’s stock, valued at approximately $375,869.86. The trade was a 65.34 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Hedge Funds Weigh In On Guardian Pharmacy Services

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Franklin Resources Inc. bought a new stake in shares of Guardian Pharmacy Services in the 3rd quarter worth approximately $8,575,000. Wellington Management Group LLP purchased a new position in shares of Guardian Pharmacy Services in the 3rd quarter worth about $8,400,000. Allspring Global Investments Holdings LLC bought a new position in Guardian Pharmacy Services in the 3rd quarter worth about $5,460,000. Maven Securities LTD purchased a new stake in Guardian Pharmacy Services during the 3rd quarter valued at about $3,033,000. Finally, Seven Grand Managers LLC bought a new stake in Guardian Pharmacy Services during the 3rd quarter valued at about $2,515,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.